The House Finance Committee heard testimony Tuesday on House Bill 195, which would allow pharmacists to independently prescribe medications for minor ailments and chronic conditions. But debate quickly focused on whether the legislation could permit abortion medication prescribing.

The bill, sponsored by Representative Mena, would clarify pharmacists' authority to provide limited primary care services and establish collaborative practice agreements with other healthcare providers. The legislation is tied to Alaska's $272 million Rural Health Transformation Program award, with a December 31, 2027 deadline for enactment.

Dr. Brandy Signa-Martin of the Alaska Pharmacy Association said the bill would not authorize pharmacists to prescribe abortion medications. She cited a legal opinion from Senior Assistant Attorney General Parker Patterson confirming the legislation "does not amend Alaska's abortion statutes."

However, Representative Allard challenged that interpretation. She presented a legal memo from Legislative Legal Services stating that "if a written protocol included prescribing and administering an abortion drug from the collaborative practicing agreement," then pharmacists could prescribe such medications. "I have grave concerns," Allard said, questioning why language explicitly prohibiting abortion medication was not included in the bill.

Representative Stapp criticized the exclusion of an Alaska State Medical Board opposition letter from the committee packet. The letter, available on the legislative database, states the bill "would effectively expand the prescription authority for pharmacists to provide and administer any medications including controlled substances and abortion medication," according to Stapp.

Mena defended the bill's focus on primary care access. She said adding abortion-specific language "would detract from the bill's goal." The Alaska Pharmacy Association argued that clarifying language could create "unintended consequences" since some drugs have multiple medical uses.

The bill would require pharmacists to practice within their education and training, refer complex cases to other providers, and complete continuing education in pain management and opioid treatment. It would also enable pharmacist participation in medication-assisted treatment for opioid use disorder and allow prescribing for conditions such as urinary tract infections, strep throat, seasonal allergies, and management of diabetes and hypertension.

The committee took no action Tuesday. The bill has support from the Alaska Hospital and Healthcare Association and Alaska Native Health Board but faces opposition from multiple medical organizations.